These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16919739)

  • 1. Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders.
    Marlowe DB
    J Subst Abuse Treat; 2006 Sep; 31(2):131-9. PubMed ID: 16919739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone as negative reinforcement comments on "A behavioral analysis of coerced treatment for addicted offenders".
    Farabee D
    J Subst Abuse Treat; 2006 Sep; 31(2):141-2. PubMed ID: 16919740
    [No Abstract]   [Full Text] [Related]  

  • 3. Judicially mandated naltrexone use by criminal offenders: a legal analysis.
    Bonnie RJ
    J Subst Abuse Treat; 2006 Sep; 31(2):121-7. PubMed ID: 16919737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
    Presenza LJ
    J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of depot naltrexone under legal coercion: the case for caution.
    Hall W; Capps B; Carter A
    Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
    [No Abstract]   [Full Text] [Related]  

  • 6. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting depot formulations of naltrexone for heroin dependence: a review.
    Krupitsky EM; Blokhina EA
    Curr Opin Psychiatry; 2010 May; 23(3):210-4. PubMed ID: 20224403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone for probationers and parolees.
    O'Brien C; Cornish JW
    J Subst Abuse Treat; 2006 Sep; 31(2):107-11. PubMed ID: 16919734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
    Rawson RA; Tennant FS
    NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of information in naltrexone study.
    Rastegar DA
    Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
    Brewer C; Wong VS
    Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    Larney S; Dolan K
    Eur Addict Res; 2009; 15(2):107-12. PubMed ID: 19182485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients".
    Rosenbloom DL
    J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694
    [No Abstract]   [Full Text] [Related]  

  • 18. The behavioral economics of violence.
    Rachlin H
    Ann N Y Acad Sci; 2004 Dec; 1036():325-35. PubMed ID: 15817747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical usefulness of narcotic antagonists: implications of behavioral research.
    Meyer RE; Mirin SM; Altman JL
    Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.